Grafa
Nufarm shares rise on strong earnings and deleveraging
Nufarm shares rise on strong earnings and deleveraging

Nufarm shares rise on strong earnings and deleveraging

Share

Agricultural chemicals giant Nufarm (ASX:NUF) announced a strong performance for the first half of the 2026 financial year, underpinned by a strategy refresh and disciplined capital management.

The company revealed that its underlying EBITDA for H1 FY26 is expected to land between $239 million and $244 million.

At the mid-point, this represents a notable 17% increase compared to the prior corresponding period, a boost driven by improved margins in crop protection, expansion in hybrid seeds, and solid gains within the emerging omega-3 and bioenergy platforms.

Beyond earnings growth, Nufarm has made substantial strides in fortifying its balance sheet. Net debt as of March 31 stood at approximately $1.23 billion, reflecting a reduction of $130 million year-on-year.

The deleveraging has brought the net debt to LTM uEBITDA ratio down to 3.6x, a 20% improvement on the pcp.

Management attributed this progress to enhanced cash generation resulting from lower capital expenditure and a rigorous approach to working capital.

Looking ahead, the company is accelerating its efficiency drive, targeting an additional $50 million in cost savings through the first stage of its strategy refresh.

With positive trading momentum reportedly continuing into April, Nufarm remains focused on sustaining this trajectory.

Perguntas frequentes

Conecte-se conosco

A Grafa não é um consultor financeiro. Você deve buscar aconselhamento independente, jurídico, financeiro, tributário ou de outra natureza que se relacione às suas circunstâncias únicas.

A Grafa não se responsabiliza por qualquer perda causada, seja por negligência ou de outra forma, decorrente do uso ou da confiança nas informações fornecidas direta ou indiretamente pelo uso desta plataforma.